Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

NCT00904826 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00904826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00904826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2009
Completion date
December 31, 2011
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

devic's disease, neuromyelitis optica